| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Vale of Leven Hospital, Loch Lomondside G83 0UA, Scotland [E. C.]; Linus Pauling Institute of Science and Medicine, Menlo Park, California 94025 [L. P.]; and Department of Pathology, University of Oregon Medical School, Portland, Oregon 97201 [B. L.]
Host resistance to neoplastic growth and invasiveness is recognized to be an important factor in determining the occurrence, the progress, and the eventual outcome of every cancer illness. The factors involved in host resistance are briefly reviewed, and the relationship between these factors and ascorbic acid metabolism is presented in detail. It is shown that many factors involved in host resistance to neoplasia are significantly dependent upon the availability of ascorbate.
1 This study was supported by research grants from the Secretary of State for Scotland. The Educational Foundation of America. The Foundation for Nutritional Advancement, The Argyll and Clyde Health Board, Scotland, and by private donations to the Linus Pauling Institute of Science and Medicine.
Received 6/14/78. Accepted 12/ 4/78.
This article has been cited by other articles:
![]() |
M. L. Heaney, J. R. Gardner, N. Karasavvas, D. W. Golde, D. A. Scheinberg, E. A. Smith, and O. A. O'Connor Vitamin C Antagonizes the Cytotoxic Effects of Antineoplastic Drugs Cancer Res., October 1, 2008; 68(19): 8031 - 8038. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rozanova, J. Z. Zhang, and D. E. Heck Catalytic Therapy of Cancer with Ascorbate and Extracts of Medicinal Herbs Evid. Based Complement. Altern. Med., December 26, 2007; (2007) nem159v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Gonzalez, J. R. Miranda-Massari, E. M. Mora, A. Guzman, N. H. Riordan, H. D. Riordan, J. J. Casciari, J. A. Jackson, and A. Roman-Franco Orthomolecular Oncology Review: Ascorbic Acid and Cancer 25 Years Later Integr Cancer Ther, March 1, 2005; 4(1): 32 - 44. [Abstract] [PDF] |
||||
![]() |
K. N. Prasad Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity Integr Cancer Ther, December 1, 2004; 3(4): 310 - 322. [Abstract] [PDF] |
||||
![]() |
S. Sieri, V. Krogh, V. Pala, P. Muti, A. Micheli, A. Evangelista, G. Tagliabue, and F. Berrino Dietary Patterns and Risk of Breast Cancer in the ORDET Cohort Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 567 - 572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vickers Alternative Cancer Cures: "Unproven" or "Disproven"? CA Cancer J Clin, March 1, 2004; 54(2): 110 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Prasad, W. C. Cole, B. Kumar, and K. C. Prasad Scientific Rationale for Using High-Dose Multiple Micronutrients as an Adjunct to Standard and Experimental Cancer Therapies J. Am. Coll. Nutr., October 1, 2001; 20(90005): 450S - 463. [Abstract] [Full Text] |
||||
![]() |
K. N. Prasad, A. Kumar, V. Kochupillai, and W. C. Cole High Doses of Multiple Antioxidant Vitamins: Essential Ingredients in Improving the Efficacy of Standard Cancer Therapy J. Am. Coll. Nutr., February 1, 1999; 18(1): 13 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hunter, J. E. Manson, G. A. Colditz, M. J. Stampfer, B. Rosner, C. H. Hennekens, F. E. Speizer, and W. C. Willett A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast Cancer N. Engl. J. Med., July 22, 1993; 329(4): 234 - 240. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |